Scalper1 News
Gene-sequencing giant Illumina (ILMN) hit another new high on the stock market today after it outlined its strategic vision at its annual investor day, and got two price target increases. Late Thursday, Illumina issued a press release unveiling its “strategic road map” following its meeting outlining its strategy to investors and analysts. The company had already announced two new sequencing systems and previewed Q4 results earlier in the week at Scalper1 News
Scalper1 News